Sponsor or institution
Clinical trials and research at Avenzo Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Avenzo Therapeutics, Inc. that are recruiting, at sites in 3 countries (most in United States (4), Australia (1), China (1)). By phase: Phase 1/2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AVZO-103 alone and with other treatments for advanced urothelial and other solid tumors | Phase 1/2 | San Francisco, California and 14 other locations | Recruiting | Sep 26, 2025 |
| AVZO-1418 alone and with other treatments for advanced epithelial solid tumors | Phase 1/2 | Gilbert, Arizona and 26 other locations | Recruiting | Jun 26, 2025 |
| AVZO-023 alone or with AVZO-021 and hormone therapy for advanced HR+/HER2- breast cancer | Phase 1/2 | Los Angeles, California and 15 other locations | Recruiting | May 31, 2025 |
| Treatment of advanced solid tumors with AVZO-021 | Phase 1/2 | New Haven, Connecticut and 12 other locations | Recruiting | May 19, 2023 |
All recruiting trials (4)
-
AVZO-103 alone and with other treatments for advanced urothelial and other solid tumors
This trial will test intravenous AVZO-103, alone and combined with other cancer drugs, to see if it is safe and helps adults with locally advanced or metastatic urothelial cancer or other solid tumors.
-
AVZO-1418 alone and with other treatments for advanced epithelial solid tumors
This trial will test whether intravenous AVZO-1418, alone or with other cancer drugs, is safe and helps adults with locally advanced or metastatic epithelial solid tumors, including some lung cancers.
-
AVZO-023 alone or with AVZO-021 and hormone therapy for advanced HR+/HER2- breast cancer
This will test whether the oral drug AVZO-023, given alone or with AVZO-021 and hormone therapy, is safe and can help control advanced HR+/HER2- breast cancer.
-
Treatment of advanced solid tumors with AVZO-021
This study is testing a new oral medication called AVZO-021 to see if it can safely help people with advanced solid tumors, especially certain types of breast cancer and other cancers with specific genetic changes.
Quick answers
How many clinical trials run by Avenzo Therapeutics, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), Australia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.